A survey reveals that the way in which genetic sequences are claimed in granted patents are heterogeneous and imprecise, which may lead to questions regarding their validity.
References
Grisham, J. Nature 18, 921 (2000).
Walker, B.W. & Carty, S.M. Nat. Biotechnol. 21, 943 (2003).
See, for example, US Patent No. 6,590,077.
See, for example, US Patent No. 6,586,202.
Caccone, A., DeSalle, R. & Powell, J.R. J. Mol. Evol. 27, 212 (1988).
Dufresne, G., Takacs, L., Heus, H., Codani, J.J. & Duval, M. Nat. Biotechnol. 20, 1269 (2002).
See, for example, US Patent No. 6,319,675.
See, for example, US Patent No. 6,589,767.
Doyle, J.J. & Gaut, B.S. Plant Mol. Biol. 42, 1 (2000).
Durbin, R., Eddy, S., Krogh, A. & Mitchison, G. Biological Sequence Analysis (Cambridge University Press, Cambridge, UK, 1998).
See, for example, EP Patent No. 668,351.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dufresne, G., Duval, M. Genetic sequences: how are they patented?. Nat Biotechnol 22, 231–232 (2004). https://doi.org/10.1038/nbt0204-231
Issue Date:
DOI: https://doi.org/10.1038/nbt0204-231
- Springer Nature America, Inc.